Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology - Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma

Journal of Cancer Research and Clinical Oncology, Supplement

Volumn 127, Issue 5, 2001, Pages 278-285

  Stokkel, M P M ^a   Draisma, A ^a   Pauwels, E K J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal tumours; FDG PET; Head and neck cancer; Hepatocellular carcinoma; Lung cancer; Sarcoma; Therapy monitoring

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT;

CANCER DIAGNOSIS; CANCER STAGING; COLORECTAL CANCER; HEAD AND NECK CANCER; HUMAN; LIVER CELL CARCINOMA; LUNG TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SARCOMA; TREATMENT OUTCOME; ARTICLE; CANCER EPIDEMIOLOGY; CANCER THERAPY; DIAGNOSTIC IMAGING; PATIENT MONITORING; QUANTITATIVE DIAGNOSIS; ADENOCARCINOMA; ANIMAL; BONE TUMOR; COLORECTAL TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EVALUATION; FEMALE; HEAD AND NECK TUMOR; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; NEOPLASM; OUTCOME ASSESSMENT; SCINTISCANNING; SOFT TISSUE TUMOR;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; EVALUATION STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); SARCOMA; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034742666     PISSN: 09439382     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Abdel-Dayem HLS, Macapinlac H, Scott A (1994) Thallium-201 chloride: a tumour imaging agent. In: Murray EP, IPC (eds) Nuclear medicine in clinical diagnosis and treatment. Churchill Livingstone, Edinburgh, UK, pp 727-735
2. Abe Y, Matsuzawa T, Fujiwara T, Fukuda H, Itoh M, Yamada K, Yamaguchi K, Sato T, Ido T (1986) Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 12: 325-328
3. Abe Y, Matsuzawa T, Fujiwara T, Itoh M, Fukuda H, Yamaguchi K, Kubota K, Hatazawa J, Tada M, Ido T, et al (1990) Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer. Int J Radiat Oncol Biol Phys 19: 1005-1010
4. Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, al Kaisi N, Miraldi F (1991) Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 32: 1508-1512
5. Adler LP, Blair HF, Williams RP, Pathria MN, Makley JT, Joyce MJ, al Kaisi N, Miraldi F (1990) Grading liposarcomas with PET using [18F]FDG. J Comput Assist Tomogr 14: 960-962
6. Bekerman C, Hoffer PB, Bitran JD (1985) The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med 15: 72-103
7. Bigler RE, Zanzonico PB, Schmall B, Conti PS, Dahl JR, Rothman L, Sgouros G, MacEwen EG (1985) Evaluation of [1-11 C]-alpha-aminoisobutyric acid for tumor detection and amino acid transport measurement: spontaneous canine tumor studies. Eur J Nucl Med 10: 48-55
8. Bischof Delaloye A, Delaloye B, Buchegger F, Gilgien W, Studer A, Curchod S, Givel JC, Mosimann F, Pettavel J, Mach JP (1989) Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study. J Nucl Med 30: 1646-1656
9. Bragg DG (1991) Current applications of imaging procedures in the patient with lung cancer. Int J Radiat Oncol Biol Phys 21: 847-851
10. Britton KE, Granowska M (1994) The diagnostic role of radio-labeled antibodies. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment. Churchill Livingstone, Edinburgh, UK, pp 779-780
11. Bruntsch U (1987) Role of systemic chemotherapy in the treatment of squamous cell carcinoma of the head and neck. Sonderb Z Strahlenther Onkol 81: 92-98
12. Chaiken L, Rege S, Hoh C, Choi Y, Jabour B, Juillard G, Hawkins R, Parker R (1993) Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 27: 455-464
13. Chang AE, Rosenberg SA, Glatstein EJ, Antman KH (1989) Sarcomas of soft-tissues. In: DeVita HS Jr VT, Rosenberg SA (eds) Principles and practice of oncology. Lippincott, Philadelphia, pp 1345-1398
14. Cutler SJ, Young IL (1975) Third national cancer survey: incidence data. NCI Monogr 41: 1
15. Davey P, Arnott SJ, Sturgeon CM (1987) Carcinoembryonic antigen as a prognostic indicator in the radiotherapeutic management of rectal cancer. Eur J Surg Oncol 13: 17-20
16. Decker DA, Drehlichman A, Jakobs J (1983) Adjuvant chemotherapy with cis-diamino-dichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck. Cancer 51: 1353-1355
17. Deitmer T, Urbanitz D (1986) Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate. Laryngorhinootologie 65: 7-10
18. Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK Jr, Pinson CW (1998) Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 133: 510-515
19. Devesa SS, Silverman DT, Young JL Jr, Pollack ES, Brown CC, Horm JW, Percy CL, Myers MH, McKay FW, Fraumeni JF Jr (1987) Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 79: 701-770
20. During A, Sauer R, Steiner W, Herbst M, Reul H (1987) Combined treatment of hypopharyngeal carcinoma. Strahlenther Onkol 163: 764-773
21. Eilber FR, Morton DL, Eckardt J, Grant T, Weisenburger T (1984) Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy. Cancer 53: 2579-2584
22. Erdi YE, Macapinlac H, Rosenzweig KE, Humm JL, Larson SM, Erdi AE, Yorke ED (2000) Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med 27: 861-866
23. Ervin TJ, Clark JR, Weichselbaum RR (1985) Multidisciplinary treatment of advanced squamous carcinoma of the head and neck. Semin Oncol 12 [4 Suppl 6]: 71-78
24. Findlay M, Young H, Cunningham D, Iveson A, Cronin B, Hickish T, Pratt B, Husband J, Flower M, Ott R (1996) Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil [see comments]. J Clin Oncol 14: 700-708
25. Fletcher BD (1991) Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation. AJR Am J Roentgenol 157: 825-833
26. Gelbard AS, Clarke LP, McDonald JM, et al (1975) Enzymatic synthesis and organ distribution studies with 13 N labeled-L-glutamine and L-glutamic acid. Radiology 116: 127-132
27. Gelbard AS, Benua RS, Laughlin JS, Rosen G, Reiman RE, McDonald JM (1979) Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate. J Nucl Med 20: 782-784
28. Ginsberg RJ, Hill LD, Eagan RT, Thomas P, Mountain CF, Deslauriers J, Fry WA, Butz RO, Goldberg M, Waters PF, et al (1983) Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86: 654-658
29. Grabbe E, Winkler R (1985) Local recurrence after sphincter-saving resection for rectal and rectosigmoid carcinoma. Value of various diagnostic methods. Radiology 155: 305-310
30. Greven KM, Williams DW 3rd, Keyes JW Jr, McGuirt WF, Watson NE Jr, Randall ME, Raben M, Geisinger KR, Cappellari JO (1994) Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation [see comments]. Cancer 74: 1355-1359
31. Griffeth LK, Dehdashti F, McGuire AH (1990) PET evaluation of soft-tissue masses with F-18-fluorodeoxyglucose. J Nucl Med 31: 746
32. Haberkorn U, Strauss LG, Dimitrakopoulou A, Engenhart R, Oberdorfer F, Ostertag H, Romahn J, van Kaick G (1991) PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 32: 1485-1490
33. Haberkorn U, Strauss LG, Dimitrakopoulou A, Seiffert E, Oberdorfer F, Ziegler S, Reisser C, Doll J, Helus F, van Kaick G (1993) Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 34: 12-17
34. Hartenstein RC, Wendt TG, Kastenbauer ER, Trott KR (1989) Simultaneous chemo-radiotherapy with 5-FU/folinic acid/cisplatinum and accelerated split-course radiation in advanced head and neck cancer. Onkologie 12: 30-32
35. Hebert ME, Lowe VJ, Hoffman JM, Patz EF, Anscher MS (1996) Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings. Am J Clin Oncol 19: 416-421
36. Hoekstra HJ, Schraffordt Koops H, Molenaar WM, Mehta DM, Sleijfer DT, Dijkhuis G, Oldhoff J (1989) A combination of intraarterial chemotherapy, preoperative and postoperative radiotherapy, and surgery as limb-saving treatment of primarily unresectable high-grade soft tissue sarcomas of the extremities. Cancer 63: 59-62
37. Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, Jingu K, Masuda K (1991) Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 32: 1655-1660
38. Iosilevsky G, Front D, Bettman L, Hardoff R, Ben Arieh Y (1985) Uptake of gallium-67 citrate and [2-3H]deoxyglucose in the tumor model, following chemotherapy and radiotherapy. J Nucl Med 26: 278-282
39. Ito K, Kato T, Tadokoro M, Ishiguchi T, Oshima M, Ishigaki T, Sakuma S (1992) Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 182: 549-552
40. Jinno K, Moriwaki S, Tanada M, Wada T, Mandai K, Okada Y (1992) Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 31: S7-12
41. Johnson RJ, Jenkins JP, Isherwood I, James RD, Schofield PF (1987) Quantitative magnetic resonance imaging in rectal carcinoma. Br J Radiol 60: 761-764
42. Jones DN, McCowage GB, Sostman HD, Brizel DM, Layfield L, Charles HC, Dewhirst MW, Prescott DM, Friedman HS, Harrelson JM, Scully SP, Coleman RE (1996) Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med 37: 1438-1444
43. Kern KA, Brunetti A, Norton JA, Chang AE, Malawer M, Lack E, Finn RD, Rosenberg SA, Larson SM (1988) Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 29: 181-186
44. Kimball PM, Brattain MG (1980) Isolation of a cellular subpopulation from a human colonic carcinoma cell line. Cancer Res 40: 1574-1579
45. Knopp MV, Strauss LG, Dimitrakopoulou A, et al (1989) Comparison of PET with F-18 fluorodeoxyglucose and CT in imaging of lung tumors (abstract). Radiology 173P: 69-70
46. Knopp MV, Bischoff H, Rimac A, et al (1994) Clinical utility of PET with FDG for chemotherapy response monitoring - a correlative study of patients with small cell lung cancer. J Nucl Med 35: 75P
47. Kubota K, Matsuzawa T, Fujiwara T, et al (1989) Comparison of C-11 methionine and F-18 fluorodeoxyglucose for the differential diagnosis of lung tumor. J Nucl Med 30: 788-789
48. Kubota K, Ishiwata K, Kubota R, Yamada S, Tada M, Sato T, Ido T (1991) Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67 [see comments]. J Nucl Med 32: 2118-2123
49. Laccourreye H, Bassot V, Lacau St Guily J, Brasnu D, Menard M, Donnadieu S, Jacquillat C (1985) [Induction chemotherapy in cancer of the upper respiratory and digestive tract. Preliminary results of the protocol combining cisplatin, 5-fluorouracil and bleomycin (CFB)]. Ann Otolaryngol Chir Cervicofac 102: 1-6
50. Lewis P, Griffin S, Marsden P, Gee T, Nunan T, Malsey M, Dussek J (1994) Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 344: 1265-1266
51. Lomas F, Dibos PE, Wagner HN Jr (1972) Increased specificity of liver scanning with the use of 67 gallium citrate. N Engl J Med 286: 1323-1329
52. Lowe VJ, Dunphy FR, Varvares M, Kim H, Wittry M, Dunphy CH, Dunleavy T, McDonough E, Minster J, Fletcher JW, Boyd JH (1997) Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 19: 666-674
53. Mack MJ, Hazelrigg SR, Landreneau RJ, Acuff TE (1993) Thoracoscopy for the diagnosis of the indeterminate solitary pulmonary nodule. Ann Thorac Surg 56: 825-830
54. Markowitz A, Saleemi K, Freeman LM (1993) Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma. Clin Nucl Med 18: 685-700
55. Martini N, Beattie EJ Jr (1977) Results of surgical treatment in Stage I lung cancer. J Thorac Cardiovasc Surg 74: 499-505
56. Minn H, Paul R, Ahonen A (1988) Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 29: 1521-1525
57. Minn H, Lapela M, Klemi PJ, Grenman R, Leskinen S, Lindholm P, Bergman J, Eronen E, Haaparanta M, Joensuu H (1997) Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38: 1907-1911
58. Nagata Y, Yamamoto K, Hiraoka M, Abe M, Takahashi M, Akuta K, Nishimura Y, Jo S, Masunaga S, Kubo S, et al (1990) Monitoring liver tumor therapy with [18F]FDG positron emission tomography. J Comput Assist Tomogr 14: 370-374
59. Nieweg OE, Pruim J, Hoekstra HJ, Paans AM, Vaalburg W, Oldhoff J, Schraffordt Koops H (1994) Positron emission tomography with fluorine-18-fluorodeoxyglucose for the evaluation of therapeutic isolated regional limb perfusion in a patient with soft-tissue sarcoma. J Nucl Med 35: 90-92
60. Nieweg OE, Pruim J, van Ginkel RJ, Hoekstra HJ, Paans AM, Molenaar WM, Koops HS, Vaalburg W (1996) Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med 37: 257-261
61. Nolop KB, Rhodes CG, Brudin LH, Beaney RP, Krausz T, Jones T, Hughes JM (1987) Glucose utilization in vivo by human pulmonary neoplasms. Cancer 60: 2682-2689
62. Okazumi S, Isono K, Enomoto K, Kikuchi T, Ozaki M, Yamamoto H, Hayashi H, Asano T, Ryu M (1992) Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment [see comments]. J Nucl Med 33: 333-339
63. Pezzi CM, Pollock RE, Evans HL, Lorigan JG, Pezzi TA, Benjamin RS, Romsdahl MM (1990) Preoperative chemotherapy for soft-tissue sarcomas of the extremities [see comments]. Ann Surg 211: 476-481
64. Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker WE (1984) Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53: 1354-1362
65. Rege SD, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, Juillard G, Maddahi J, Phelps ME, Hawkins RA (1993) Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 189: 807-812
66. Reiman RE, Huvos AG, Benua RS, Rosen G, Gelbard AS, Laughlin JS (1981) Quotient imaging with N-13 L-glutamate in osteogenic sarcoma: correlation with tumor viability. Cancer 48: 1976-1981
67. Reiman RE, Rosen G, Gelbard AS, Benua RS, Laughlin JS (1982) Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology 142: 495-500
68. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G (1983) Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 52: 1317-1329
69. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart Willems J (1996) Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 23: 1641-1674
70. Rohrmeier M, Langnickel R, Hilpert P (1987) Results of an interdisciplinary study of primary inoperable stage T3 and T4 squamous cell carcinoma of the mouth, oropharynx and hypopharynx. HNO 35: 14-18
71. Rothman H (1985) Changing trends in treatment of advanced head and neck carcinoma: review of the literature and report of a case. J Am Osteopath Assoc 85: 370-374
72. Sakamoto HNY, Ohashi Y, Matsuda M (1998) Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas. Acta Otolaryngol 538: 254-260
73. Sakurai M, Okamura J, Kuroda C (1984) Transcatheter chemoembolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer 54: 387-392
74. Sankaranarayanan RME, Swaminathan R, Ferlay J, Whelan S (1998) Head and neck cancer: a global perspective on epidemiology and prognosis. anticancer research 18: 4779-4786
75. Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S, Kojima J, Ishikawa O, Ohigashi H, Furukawa H, et al (1987) A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 60: 1194-1203
76. Schiepers C, Penninckx F, De Vadder N, Merckx E, Mortelmans L, Bormans G, Marchal G, Filez L, Aerts R (1995) Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 21: 517-522
77. Schlag P, Lehner B, Strauss LG, Georgi P, Herfarth C (1989) Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy. Arch Surg 124: 197-200
78. Schmall B, Conti PS, Bigler RE, Zanzonico PB, Reiman RE, Benua RS, Yeh SD, Dahl JR, Lee R, Laughlin JS (1987) Imaging studies of patients with malignant fibrous histiocytoma using C11-alpha-aminoisobutyric acid (AIB). Clin Nucl Med 12: 22-26
79. Schroder M, von Heyden HW, Scherpe A, Nagel GA (1986) Effect of chemotherapy on the survival of patients with far-advanced squamous cell carcinoma of the head and neck. A comparative matched-pair analysis of conventional therapeutic procedures with and without chemotherapy. Laryngol Rhinol Otol Stuttg 65: 11-15
80. Shibata T, Yamamoto K, Hayashi N, Yonekura Y, Nagara T, Saji H, Mukai T, Konishi J (1988) Dynamic positron emission tomography with 13N-ammonia in liver tumors. Eur J Nucl Med 14: 1986-1990
81. Shields AF, Mankoff DA, Link JM, Graham MM, Eary JF, Kozawa SM, Zheng M, Lewellen B, Lewellen TK, Grierson JR, Krohn KA (1998) Carbon-11-thymidine and FDG to measure therapy response. J Nucl Med 39: 1757-1762
82. Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, Oster ZH, Sacker DF, Shiue CY, Turner H, Wan CN, Wolf AP, Zabinski SV (1980) A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21: 670-675
83. Stokkel MPM, ten Broek FW, van Rijk PP (1998) The role of FDG PET in the clinical management of head and neck cancer. Oral Oncology 34: 466-471
84. Strauss LG, Clorius JH, Schlag P, Lehner B, Kimmig B, Engenhart R, Marin Grez M, Helus F, Oberdorfer F, Schmidlin P, et al (1989) Recurrence of colorectal tumors: PET evaluation. Radiology 170: 329-332
85. Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32: 623-648
86. Torizuka T, Tamaki N, Inokuma T, Magata Y, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J (1994) Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 35: 1965-1969
87. Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J (1995) In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 36: 1811-1817
88. Trojan J, Schroeder O, Raedle J, Baum RP, Herrman GVJSZ (1999) Fluorine-18 FDG positron emission tomography for imaging hepatocellular carcinoma. Eur J Nucl Med 94: 3314-3319
89. Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, Myers RW, Lutrin CL (1995) Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 60: 1573-1581
90. Wahl RL, Cody RL, Hutchins GD, Mudgett EE (1991) Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 179: 765-670
91. Williams DE, Pairolero PC, Davis CS, Bernatz PE, Payne WS, Taylor WF, Uhlenhopp MA, Fontana RS (1981) Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 82: 70-76
92. Yonekura Y, Benua RS, Brill AB, Som P, Yeh SD, Kemeny NE, Fowler JS, MacGregor RR, Stamm R, Christman DR, Wolf AP (1982) Increased accumulation of 2-deoxy-2-[18F]fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 23: 1133-1137